Topadur Pharma receives new funding from Innosuisse
News 05.01.2024 Zurich-Schlieren, Switzerland, January 5th, 2024 Swiss biotech start-up Topadur Pharma AG is pleased to announce that it has been awarded a Start-up Innovation Project grant from Innosuisse. With this funding, Innosuisse is supporting a Proof-of-Concept, Phase 2a clinical trial in patients with digital ulcers (DU) in systemic sclerosis (SSc).The grant of...